Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | TriMark Publications | Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking

Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking

Insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are all serious sleep disorders that possess negative-and sometimes fatal-health consequences. Often undiagnosed and thus not treated, sleep disorders can not only take a toll on personal health but can also adverse effects on personal relationships and reduce worker productivity. In examining the troubling increase in a variety of sleep disorders, this TriMark Publications report will analyze the causes and available treatments for sleep disorder sufferers. This is a particularly interesting time in the evolution of the sleep disorders market because the blockbuster drugs that have dominated this space are coming off patent protection. There has been a strong push on the part of the major pharmaceutical companies to develop or acquire replacement sources of revenue. In order to put sleep disorders in a proper context, the study begins with an examination of key characteristics of the overall sleep disorders market. The types of disorders, causes of insomnias, parasomnias and their treatments are analyzed, with the additional review of treatments including pharmaceuticals, devices (continuous positive airway pressure or CPAP machines) and others (nutraceuticals, etc.). The report goes on to describe the primary product offerings of the major companies in this market space including major classes of prescription and over-the-counter (OTC) pharmaceuticals. Finally, a review of companies developing treatments for insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are examined.

Publication Date: 01-MAR-09

Pages: 292

Study: TMRSLD

Format/Price: PDF document / $3,400.00
Table of Contents
Price: $3,400.00 / €2,272.56

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions